CLINICAL_TRIALS
trial_result
· 2010-07-12
Clinical Trial Update: Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema [Phase 2]
Summary
Phase 2 study of LAS 41002 for atopic dermatitis has completed. The sponsor is Almirall, S.A.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Almirall, S.A. | Conditions: Atopic Eczema | Phase 2 | Status: COMPLETED